Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia

The New England Journal of Medicine
M E EysterO T Preble

Abstract

Many homosexual men with the acquired immunodeficiency syndrome (AIDS) have an unusual acid-labile form of human leukocyte, or alpha, interferon in their serum. Male patients with classic hemophilia treated with lyophilized clotting-factor concentrates are also at high risk for the development of AIDS. To determine whether the level of alpha interferon may be a preclinical marker of early subclinical disease, we examined stored plasma and serum from three hemophilic patients with AIDS. Persistently elevated levels of the acid-labile form of alpha interferon were found in all three patients. In two patients the appearance of circulating alpha interferon preceded the onset of clinical disease by 3 to 10 months. In contrast, alpha-interferon levels were not elevated in 43 of 46 unselected patients with hemophilia; three of these patients had transient elevations. These results suggest that acid-labile alpha interferon may be a marker that can be used to identify affected asymptomatic members of high-risk groups before the onset of clinical disease.

References

Feb 20, 1982·Lancet·J J GoedertW A Blattner
May 15, 1982·Lancet·M MarmorN Dubin
Jan 13, 1983·The New England Journal of Medicine·M M LedermanB Schacter
Jun 1, 1982·Annals of Internal Medicine·A E Friedman-KienS Zolla-Pazner
Jul 3, 1982·British Medical Journal·J GerstoftI Lorenzen
Oct 1, 1982·The Journal of Infectious Diseases·E DeStefanoJ Vilcek

❮ Previous
Next ❯

Citations

Oct 1, 1986·European Journal of Clinical Microbiology·T BergströmK Thorén
Jan 1, 1990·Biotherapy·S E Krown
Mar 29, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Erin E McClelland, Jennifer M Smith
Sep 14, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·M M MüllerC H Huber
Sep 8, 1983·The New England Journal of Medicine·J W Curran
Apr 5, 1984·The New England Journal of Medicine
Jan 31, 1985·The New England Journal of Medicine·N C ZoumbosN S Young
Jan 1, 1983·AIDS Research·J C GoldsmithG W Hunninghake
Jan 1, 1987·AIDS Research and Human Retroviruses·L RatnerN Ruddle
Aug 1, 1988·AIDS Research and Human Retroviruses·O YamadaT Kishida
Jul 1, 1990·AIDS Research and Human Retroviruses·A CarusoA Turano
Jun 1, 1991·AIDS Research and Human Retroviruses·A S LauB R Williams
Feb 1, 1992·AIDS Research and Human Retroviruses·M RoedererL A Herzenberg
May 1, 1992·AIDS Research and Human Retroviruses·M R CapobianchiF Dianzani
Jun 9, 2009·AIDS Research and Human Retroviruses·C LehmannF Romerio
Feb 1, 1988·Journal of Interferon Research·A RuffaultB Fauconnier
Dec 1, 1991·Journal of Interferon Research·P M Pitha
Dec 1, 1992·Journal of Interferon Research·M R CapobianchiF Dianzani
May 1, 1992·Journal of Interferon Research·A RuffaultB Fauconnier
Feb 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·S SwindellsH E Gendelman
Sep 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D D VakhariaS A Rich
Oct 1, 1992·Neuropathology and Applied Neurobiology·P G Kennedy, J Gairns
Feb 1, 1997·Molecular Pathology : MP·A N al-MasriP von Wussow
Feb 11, 2010·Journal of Leukocyte Biology·Patricia Fitzgerald-Bocarsly, Evan S Jacobs
Jun 1, 1985·European Journal of Clinical Microbiology·K HuygenN Clumeck
Oct 1, 1985·Genitourinary Medicine·J N WeberJ R Harris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.